About | Free Trial

Last Update

2016-01-28T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Wrong Achim Knappik?

Dr. Achim Knappik

Head of Research and Development

AbD Serotec Ltd

Direct Phone: +49 **********       

AbD Serotec Ltd

4350 Lassiter at North Hills Ave

Raleigh, North Carolina 27609

United States

Company Description

AbD Serotec is the research antibody division of MorphoSys, one of the world's leading human antibody technology companies with sales offices in Germany (Munich), the U.S. (Raleigh, NC), the U.K. (Oxford) and France. AbD Serotec's comprehensive product ca... more

Find other employees at this company (79)

Background Information

Employment History

Head of Research and Development AbD Serotec

Bio-Rad Laboratories Inc

Education

PhD

Web References (104 Total References)


Der Industrie mangelt es an ...

www.oem.abdserotec.com [cached]

Der Industrie mangelt es an Antigen-spezifischen, vollständig menschlichen und insbesondere monoklonalenAntikörper eines bestimmten Isotyps in reproduzierbarer Qualität - alles Anforderungen, die unsere HuCAL-Technologie perfekt erfüllen kann", erklärt Dr. Achim Knappik, Head of R&D, AbD Serotec.


Dr. Achim Knappik, Head of ...

www.oem.abdserotec.com [cached]

Dr. Achim Knappik, Head of R&D at AbD Serotec commented, "Today's news further exemplifies the unique flexibility of our HuCAL antibody platform and the broad range of potential applications which we can target. e2v's approach to establish a novel type of point of care system is highly innovative and very interesting both scientifically and commercially.


AbD Serotec News Releases - AbD Serotec

www.abdserotec.com [cached]

"Today's news marks yet another promising development of a pre-existing customer relationship of AbD Serotec," comments Dr. Achim Knappik, Head of R&D at AbD Serotec.


AbD Serotec News Releases - AbD Serotec

www.abdserotec.com [cached]

Dr. Achim Knappik, Head of R&D at AbD Serotec commented, "Today's news further exemplifies the unique flexibility of our HuCAL antibody platform and the broad range of potential applications which we can target. e2v's approach to establish a novel type of point of care system is highly innovative and very interesting both scientifically and commercially.


AbD Serotec News Releases - AbD Serotec

www.abdserotec.com [cached]

Der Industrie mangelt es an Antigen-spezifischen, vollständig menschlichen und insbesondere monoklonalenAntikörper eines bestimmten Isotyps in reproduzierbarer Qualität - alles Anforderungen, die unsere HuCAL-Technologie perfekt erfüllen kann", erklärt Dr. Achim Knappik, Head of R&D, AbD Serotec.

Similar Profiles

Other People with this Name

Other people with the name Knappik

Gregor Knappik
Atmel Corporation

Christian Knappik
NORDFOLIEN GmbH

Andy Knappik
Radeberger Gruppe KG

Sarah Knappik
TV

Christina Knappik
Virgin Money

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory